Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018420
Filing Date
2019-06-27
Accepted
2019-06-27 17:12:35
Documents
2
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6247
2 EX-24 DOCUMENT attachment1.htm EX-24 4246
  Complete submission text file 0000899243-19-018420.txt   11824
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARUNA THERAPEUTICS, INC. 33 ARCH STREET, SUITE 3110 BOSTON MA 02110
Business Address
Miller Andrew Craig (Reporting) CIK: 0001777760 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 19926255